Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma. | PeerJ | 2020 | 33304653 | PubTator, text mining | PubMed |
| Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma. | J Immunol Res | 2020 | 33294468 | PubTator, text mining | PubMed |
| Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. | Nat Commun | 2020 | 33293583 | PubTator, text mining | PubMed |
| Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer. | World J Surg Oncol | 2020 | 33292276 | PubTator, text mining | PubMed |
| ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments. | Cancer Cell Int | 2020 | 33292231 | PubTator, text mining | PubMed |
| Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma. | Front Endocrinol (Lausanne) | 2020 | 33281749 | PubTator, text mining | PubMed |
| RNA sequencing: new technologies and applications in cancer research. | J Hematol Oncol | 2020 | 33276803 | PubTator, text mining | PubMed |
| Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. | Int J Nanomedicine | 2020 | 33262592 | PubTator, text mining | PubMed |
| Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives. | Cell Regen | 2020 | 33258056 | PubTator, text mining | PubMed |
| Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods. | 3 Biotech | 2020 | 33251083 | PubTator, text mining | PubMed |
| Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers. | Sci Rep | 2020 | 33247170 | PubTator, text mining | PubMed |
| SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma. | Front Genet | 2020 | 33244319 | PubTator, text mining | PubMed |
| Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4. | J Immunother Cancer | 2020 | 33243932 | PubTator, text mining | PubMed |
| Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer. | PeerJ | 2020 | 33240685 | PubTator, text mining | PubMed |
| Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2020 | 33224866 | PubTator, text mining | PubMed |
| Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma. | Aging (Albany NY) | 2020 | 33223512 | PubTator, text mining | PubMed |
| ACAA1 Is a Predictive Factor of Survival and Is Correlated With T Cell Infiltration in Non-Small Cell Lung Cancer. | Front Oncol | 2020 | 33194642 | PubTator, text mining | PubMed |
| TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma. | Front Genet | 2020 | 33193690 | PubTator, text mining | PubMed |
| Visualizing Dynamic Changes at the Maternal-Fetal Interface Throughout Human Pregnancy by Mass Cytometry. | Front Immunol | 2020 | 33193353 | PubTator, text mining | PubMed |
| CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. | Int J Mol Sci | 2020 | 33182504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=59